Dr. Heng hosted 2019 AACR IME workshop participants at BIDMC and gave a presentation on how to leverage tissue resources for molecular epidemiology research.
Dr. Y. Guzman-Arocho's abstract, "Breast Histopathologic Features Associated with Long-Term Testosterone Therapy in Transgender Individuals", has been selected for platform presentation at the United States and Canadian Academy of Pathology (USCAP) 2020 meeting. Congratulations!
Dr. Heng's abstract, "Tobacco use, alcohol consumption, and breast cancer somatic genomic alterations" will be presented as a Poster at the 2019 San Antonio Breast Cancer Symposium.
Dr Heng was invited by NCI Center to Reduce Cancer Health Disparities (CRCHD) to share her story about the moment that inspired her to work in transgender cancer research. https://twitter.com/NCICRCHD/status/1665818273626353666?s=20
NCI Division of Cancer Biology (DCB) highlighted Dr. Heng's DCB-supported breast cancer research on Twitter/X for Breast Cancer Awareness in October. https://x.com/NCICancerBio/status/1717988909551071461?s=20
Leveraging an artificial intelligence algorithm created by Dr. Heng's team to analyze breast tissue composition—the relative amounts of breast epithelium, fibrous stroma, and fat—the findings suggest that gender-affirming testosterone therapy may decrease the breast cancer risk for trans masculine...
Dr. Heng has been selected to participate in the 2025 SGM Cancer Curriculum Advances Research Excellence (CARE) Workshop in Denver, CO. She will also present relevant basic cancer research that she is leading at the workshop.
Dr. Heng will be presenting, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer." at the 2025 Harvard Institute for RNA Medicine (HiRM) seminar series on Tuesday, February 18th at 3 pm.
Dr Heng was awarded the Molecular Pathological Epidemiology Rising Investigator Award at the recently concluded 3rd International Molecular Pathological Epidemiology Meeting. http://ogino-mpe-lab.dana-farber.org/